Market Cap 13,000.00
Revenue (ttm) 1.56M
Net Income (ttm) -880,000.00
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -56.41%
Debt to Equity Ratio 0.00
Volume 100
Avg Vol 10,040
Day's Range N/A - N/A
Shares Out 66.65M
Stochastic %K 25%
Beta -11.91
Analysts Strong Buy
Price Target $6.00

Company Profile

Acura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, si...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 847 705 7709
Fax: 847 705 5399
Address:
616 N. North Court, Suite 120, Palatine, United States
DickJuice
DickJuice May. 8 at 12:36 AM
$ACUR https://contracts.justia.com/companies/acura-pharmaceuticals-inc-7140/contract/294147/ Bankruptcy coming??
0 · Reply
teamgreen
teamgreen Dec. 8 at 9:35 PM
0 · Reply
Diretoban
Diretoban Jun. 11 at 10:43 AM
$ACUR https://www.pharmacytimes.com/view/because-ned-said-new-technology-helps-prevent-opioid-overdose
0 · Reply
SenMars
SenMars Feb. 11 at 12:32 AM
0 · Reply
Latest News on ACUR
No data available.
DickJuice
DickJuice May. 8 at 12:36 AM
$ACUR https://contracts.justia.com/companies/acura-pharmaceuticals-inc-7140/contract/294147/ Bankruptcy coming??
0 · Reply
teamgreen
teamgreen Dec. 8 at 9:35 PM
0 · Reply
Diretoban
Diretoban Jun. 11 at 10:43 AM
$ACUR https://www.pharmacytimes.com/view/because-ned-said-new-technology-helps-prevent-opioid-overdose
0 · Reply
SenMars
SenMars Feb. 11 at 12:32 AM
0 · Reply